|
Original Reports
1. Dreyer EB, Kaiser PK, Offermann JT, and Lipton SA. HIV-1
coat protein increases intracellular Ca2+ and injures neurons:
toxicity prevented by calcium channel antagonists. Science
248:364-367 (1990). [Accompanying editorial on p. 303]
2. Kaiser PK, Offermann JT, and Lipton SA. Neuronal injury
due to HIV-1 envelope protein is blocked by anti-gp120 antibodies
but not by anti-CD4 antibodies. Neurology 40:1757-1761 (1990).
3. Kaiser PK and Lipton SA. VIP-mediated increase in cAMP
prevents TTX-induced retinal ganglion cell death in vitro.
Neuron 5:373-381 (1990).
4. Lipton SA, Sucher NJ, Kaiser PK, and Dreyer EB. Synergistic
effects of HIV coat protein and NMDA receptor-mediated neurotoxicity.
Neuron 7:111-118 (1991).
5. Kaiser PK, Pineda RP, Albert DM, and Shore JW. Recognition
of "Black Cornea" after Long Term Epinephrine Use.
Archives of Ophthalmology 110(9):1273-1275 (1992).
6. Kaiser PK and the Corneal Abrasion Patching Study Group.
A comparison of pressure patching versus no patching for corneal
abrasions due to trauma or foreign body removal. Ophthalmology
102(12):1936-1942 (1995).
7. Kaiser PK and Gragoudas ES. The subretinal fibrosis and
uveitis syndrome International Ophthalmology Clinics 36(1):145-52
(1996).
8. Kaiser PK, Pineda RP, and the Corneal Abrasion Patching
Study Group. A study of topical non-steroidal anti-inflammatory
drops and no pressure patching in the treatment of corneal
abrasions. Ophthalmology 104(8):1353-1359 (1997).
9. Kaiser PK, Murray TG, and O'Brien JM. Laser photocoagulation
of retinal and choroidal tumors. Ophthalmic Surgery and Lasers
29(1): 59-78 (1998).
10. Sanislo SR, Lowder CL, and Kaiser PK. Optic nerve head
neovascularization in an AIDS patient with inactive CMV retinitis
on protease inhibitors. American Journal of Ophthalmology
126(2):318-320 (1998).
11. Simons BD, Flynn HW, Kaiser PK, and Munoz M. Bilateral
choristomas in the ocular adnexa, lids, and posterior segment.
Retina 18(4):380-382 (1998).
12. Clark WL, Kaiser PK, Flynn HW, Balfort A, Miller D, and
Meisler D. Treatment strategies and visual acuity outcomes
in chronic postoperative Propionibacterium acnes endophthalmitis.
Ophthalmology 106:1665-1670 (1999).
13. Lewis H, Kaiser PK, Lewis S, and Estafanous E. Macular
translocation for subfoveal choroidal neovascularization in
age-related macular degeneration: A prospective study. American
Journal of Ophthalmology 128(2):135-146 (1999).
14. You TT, Kaiser PK, Netland TP, Jakobiec FA. Neurothekeoma
palpebrae: a rare nerve sheath tumor arising in the eyelid.
Ophthal Plast Reconstr Surg 15(6):448-449 (1999).
15. Treatment of Age-related Macular Degeneration with Photodynamic
Therapy (TAP) Study Group. Photodynamic therapy of subfoveal
choroidal neovascularization in age-related macular degeneration
with verteporfin: One year results of 2 randomized clinical
trials- TAP Report #1. Archives of Ophthalmology 117:1329-1345
(1999). [Writing Committee]
16. Kaiser PK. Web-based Publishing: A New Frontier. Ophthalmology
Clinics of North America. 13(2):1-8 (2000).
17. Kaiser PK. Photodymanic therapy with verteporfin for
choroidal neovascularization. Today's Therapeutic Trends 18(4):313-326
(2000).
18. Estafanous E, Kaiser PK, Baerveldt G. Retrobulbar chlorpromazine
in blind and seeing painful eyes. Retina 20(5):555-8 (2000).
19. Sanislo SR, Lowder CY, Kaiser PK, Gutman FA, Zegarra
H, Dodds EM, Dailey JP, Meisler DM, and Cunningham ET. Corticosteroid
therapy for optic nerve disc neovascularization secondary
to chronic vitritis. American Journal of Ophthalmology 130(6):724-31
(2000).
20. Kaiser PK, Riemann CR, Sears JE, Lewis H. Macular traction
detachment and diabetic macular edema associated with posterior
hyaloidal traction. American Journal of Ophthalmology 131:44-49
(2001).
21. Verteporfin in Photodynamic Therapy (VIP) Study Group.
Photodynamic therapy of subfoveal choroidal neovascularization
in pathologic myopia with verteporfin: One year results of
a randomized clinical trial- VIP Report #1. Ophthalmology
108(5):841-852 (2001). [Writing Committee]
22. Treatment of Age-related Macular Degeneration with Photodynamic
Therapy (TAP) Study Group. Photodynamic therapy of subfoveal
choroidal neovascularization in age-related macular degeneration
with verteporfin: Two year results of 2 randomized clinical
trials- TAP Report #2. Archives of Ophthalmology 119(2):198-207
(2001). [Writing Committee]
23. Verteporfin in Photodynamic Therapy (VIP) Study Group.
Verteporfin therapy of subfoveal choroidal neovascularization
in age-related macular degeneration: 2 year results of a randomized
clinical trial including lesions with occult with no classic
choroidal neovascularization -VIP Report #2. American Journal
of Ophthalmology 131(5):541-560 (2001). [Writing Committee]
24. Roth DB, Scott IU, Murray TG, Kaiser PK, Feuer WJ, Hughes
R, and Rosa RH. Echography of retinoblastoma: Histopathologic
correlation and serial evaluation after globe-conserving radiotherapy
or chemotherapy. Journal of Pediatric Ophthalmology and Strabismus
38(3):136-143 (2001).
25. Jeng BH, Kaiser PK, and Lowder CY. Retinal vasculitis
and posterior pole "hypopyons" as early signs of
acute bacterial endophthalmitis. American Journal of Ophthalmology
In press
26. Kaiser PK, Sullivan P, Lowder CY, Sanislo SR, Kozmorsky
GS, Rice TW, Meziane MA, and Meisler DM. Chest computerized
tomography in the work-up of chronic uveitis. American Journal
of Ophthalmology In press.
27. Sullivan P and Kaiser PK. Bilateral, endogenous endophthalmitis
caused by HACEK microorganism. American Journal of Ophthalmology,
In press.
28. Verteporfin Roundtable 2000 Participants. Guidelines
for using Verteporfin (Visudyne) in photodynamic therapy to
treat choroidal neovascularization due to age-related macular
degeneration. Retina In press. [Writing Committee]
29. Sullivan P and Kaiser PK. Current management options
in diabetic retinopathy. Cleveland Clinic Journal of Medicine
In press.
Invited Papers
1. Kaiser PK. Study takes the pressure off patching. Ophthalmology
Times 21(15):1 (1996).
2. Kaiser PK. Avoid patching small abrasions. Ophthalmology
Times 21(18):21 (1996).
3, Kaiser PK, Murray TG, and Flynn HW. Management of acute
onset postoperative endophthalmitis. DORC VitreoTech 2(1):3-8
(1997).
4. Kaiser PK and Lewis HL. The illuminated, angled, diamond
knife: A new surgical technique for removal of proliferative
diabetic fibrovascular traction. DORC VitreoTech, 3(2):2-8
(1999).
5. Kaiser PK. How to assess your practice's potential. Ophthalmology
Management, 10(Suppl):8-9 (2000).
6. Kaiser PK. Putting verteporfin therapy into practice.
Ophthalmology Management, 10(Suppl):10-13 (2000).
7. Moshfieghi DM and Kaiser PK. New Ammunition in the war
against AMD. Ophthalmology Management, 7(Suppl):14-16(2000).
8. Kaiser PK. Extending photodynamic therapy to new patients.
Ophthalmology Management, 10(Suppl):4-6 (2001).
9. Kaiser PK and Rosenfeld PJ. Treating pathologic myopia
and ocular histoplasmosis syndrome. Ophthalmology Management,
10(Suppl):11-12 (2001).
10. Kaiser PK. Comparing Verteporfin therapy to other treatments.
Ophthalmology Management, 10(Suppl):13 (2001).
11. Kaiser PK. Managing your practice efficiently. Ophthalmology
Management, 10(Suppl):14 (2001).
12. Diagnosis, treatment, and management of choroidal neovascularization
in age-related macular degeneration, Ocular Surgery News,
In press.
13. Retinal Disease in the 21st Century: Current and Future
Applications of Verteporfin. Ophthalmology Times, In press
Electronic Publications
1. Kaiser PK and Lessell S. Saturday night retinopathy. Digital
Journal of Ophthalmology 1:6 (1995).
2. Kaiser PK. Opsoclonus. Digital Journal of Ophthalmology
1:9 (1995).
3. Kaiser PK. Iridocorneal endothelial syndrome. Digital
Journal of Ophthalmology 1:12 (1995).
4. Kaiser PK and Rubin PAD. Adenoid cystic carcinoma. Digital
Journal of Ophthalmology 2:6 (1996).
Abstracts
1. Kaiser PK. A study of the effects of vasoactive intestinal
peptide on natural cell death of retinal ganglion cells. Summa
cum laude honors thesis; Harvard College, Cambridge, MA (1988).
2. Kaiser PK and Lipton SA. Vasoactive intestinal peptide
via cAMP rescues mammalian retinal ganglion cells from tetrodotoxin-induced
death. Society for Neuroscience 14:366 (1988).
3. Kaiser PK, Offermann JT, Campo R, Arroyo JG, Lamperti
E, and Lipton SA. AIDS virus envelope protein gp120 kills
rodent retinal ganglion cells in vitro. Society for Neuroscience
15:143 (1989).
4. Campo R, Offermann JT, Arroyo JG, Kaiser PK, Chen HS V,
and Lipton SA. Calcium channel antagonists partially prevent
neuronal cell killing by HIV-1 coat protein gp120 in vitro.
Society for Neuroscience 15:143 (1989).
5. Lipton SA, Kaiser PK, Offermann JT, and Dreyer EB. HIV-1
coat protein gp120 increases intracellular Ca2+ and injures
central neurons: toxicity prevented by Ca2+ channel antagonists.
Neurology (Suppl. 1) 40:273 (1990).
6. Lipton SA, Kaiser PK, Sucher NJ, Dreyer EB, and Offermann
JT. AIDS virus coat protein sensitizes neurons to NMDA receptor-mediated
toxicity. Society for Neuroscience 16:289 (1990).
7. Dreyer EB, Kaiser PK, Offermann JT, and Lipton SA. AIDS
virus coat protein-induced increases in [Ca2+] and neurotoxicity
are not prevented by anti-CD4 antibodies in rat retinal ganglion
cells. Society for Neuroscience 16:610 (1990).
8. Lipton SA, Kaiser PK, Offermann JT, Sucher NJ, and Dreyer
EB. AIDS virus coat protein gp120 increases calcium and injures
neurons in culture: detrimental effects attenuated by calcium
channel antagonists. European Journal of Neuroscience (Suppl.
3) 4108 (1990).
9. Lipton SA, Kaiser PK, Sucher NJ, and Dreyer EB. NMDA antagonists
prevent neurotoxicity from HIV coat protein gp120. Neurology
41(Suppl. 1):288 (1991).
10. Kaiser PK. Central neuron injury secondary to the AIDS
virus envelope protein, gp120, and its prevention by calcium
channel and NMDA receptor antagonists. Magna cum laude honors
thesis; Harvard Medical School, Boston, MA (1992).
11. Samy CN, Lui CJ, Kaiser PK, Lipton SA, and Dreyer EB.
Toxicity of chronic glutamate administration to the retina.
Investigative Ophthalmology & Visual Science 35:497 (1994).
12. Kaiser PK, Gonzalez VH, Theodossiadis P, Gragoudas ES,
and Miller J. Importance of time interval between indocyanine
green dye administration and diode laser transpupillary choroidal
vessel photocoagulation. Investigative Ophthalmology &
Visual Science 35(Suppl):1166 (1994).
13. Grosskreutz CL, Kaiser PK, and Dreyer EB. An evaluation
of the risk of glaucoma secondary to inhaled steroid use.
Investigative Ophthalmology & Visual Science 35(Suppl):4257
(1994).
14. Kaiser PK and the Corneal Abrasion Patching Study Group.
A comparison of pressure patching versus no patching for traumatic
corneal abrasions. Paper presented at the American Academy
of Ophthalmology Annual Meeting, San Francisco, CA, November
(1994).
15. Kaiser PK, Heng JE, Vorwerk CK, and Dreyer EB. Ethambutol
mediated optic neuropathy: a role for endogenous zinc in controlling
NMDA toxicity. Investigative Ophthalmology & Visual Science
36(Suppl):798 (1995).
16. Nguyen QD, Kaiser PK, and Dreyer EB. The buphthalmic/glaucomatous
rabbit eye: Amino acid analyses. Investigative Ophthalmology
& Visual Science 36(Suppl):4467 (1995).
17. Kaiser PK. The subretinal fibrosis and uveitis syndrome:
A unique clinical entity or final common pathway? Aegean Retina
IV, Santorini, Greece, July (1995).
18. Kaiser PK, Pineda RP, and the Corneal Abrasion Patching
Study Group. A study of topical non-steroidal anti-inflammatory
drops and no pressure patching in the treatment of corneal
abrasions. Paper presented at the American Academy of Ophthalmology
Annual Meeting, Atlanta, GA, October (1995).
19. Kaiser PK, Heng JE, Vorwerk CK, and Dreyer EB. Ethambutol
related optic neuropathy is mediated through perturbation
of mitochondrial calcium. Investigative Ophthalmology &
Visual Science 37(Suppl):4805 (1996).
20. Shiuey YC, Kaiser PK, and Young JA. Digital Journal of
Ophthalmology: A peer reviewed journal on the world wide web.
Paper presented at the American Academy of Ophthalmology Annual
Meeting, Chicago, IL, October (1996).
21. Clark WL, Kaiser PK, Miller D, and Flynn HW. Causative
organisms and antibiotic sensitivities of culture positive
endophthalmitis: A ten year review. Investigative Ophthalmology
& Visual Science 38(Suppl):5386 (1997).
22. Kaiser PK, Roth DB, Scott IU, and Murray TG. Serial echographic
characterization of retinoblastoma after radiation therapy,
laser photocoagulation, and/or cryotherapy. Investigative
Ophthalmology & Visual Science 38(Suppl):1816 (1997).
23. Kaiser PK. Causative organisms and antibiotic sensitivities
of culture positive endophthalmitis: A ten year review. Bascom
Palmer Eye Institute Annual Alumni Meeting, Miami, FL, June
(1997).
24. Sanislo SR, Kaiser PK, and Lowder CL. Optic nerve neovascularization
in an AIDS patient with inactive CMV retinitis on protease
inhibitors. Paper presented at the Ocular Microbiology and
Immunology Group, San Francisco, CA, October (1997)
25. Lowder CY, Sanislo SR, Meisler DM, Kozmorsky GS, Rice
TW, Meziane MA, and Kaiser PK. Chest computerized tomography
in the work-up of uveitis. Paper presented at the American
Uveitis Symposium, Breckenridge, CO, January (1998).
26. Sanislo SR, Lowder CY, Zegarra H, Dailey JP, Gutman FA,
and Kaiser PK. Corticosteroid therapy for optic nerve neovascularization
secondary to chronic vitritis. Paper presented at the American
Uveitis Symposium, Breckenridge, CO, January (1998).
27. Kaiser PK and Lewis HL. A new, angled, illuminated, diamond
knife for the treatment of diabetic fibrovascular proliferation.
Paper presented at 17th Annual Squaw Valley Retina Symposium,
Squaw Valley, CA, January (1998).
28. Sanislo SR, Lowder CY, Zegarra H, Dailey JP, Gutman FA,
and Kaiser PK. Corticosteroid therapy for optic nerve neovascularization
secondary to chronic vitritis. Investigative Ophthalmology
& Visual Science 39(Suppl):2837 (1998).
29. Ting TD, Meisler DM, Kaiser PK, Hall GS, Doyle LJ, Tuohy
M, Lowder CY. Prevalence of Propionibacterium acnes in the
lid and conjunctiva of normal subjects. Investigative Ophthalmology
& Visual Science 39(Suppl):660 (1998).
30. Clark WL, Flynn HW, Kaiser PK, Balfour A, and Miller
D. Treatment strategies and visual outcomes in chronic postoperative
Propionibacterium acnes endophthalmitis. Investigative Ophthalmology
& Visual Science 39(Suppl):3041 (1998).
31. Lowder CY, Sanislo SR, Meisler DM, Kozmorsky GS, Rice
TW, Meziane MA, and Kaiser PK. Chest computerized tomography
in the work-up of uveitis. Ocular Immunology and Inflammation
6(Suppl):S3 (1998).
32. Ting TD, Meisler DM, Kaiser PK, Hall GS, Doyle LJ, Tuohy
M, and Lowder CY. Prevalence of Propionibacterium acnes in
the lids and conjunctiva of normal subjects. Paper presented
at Cleveland Clinic Foundation Eye Institute Annual Resident's
Research Day, Cleveland, OH, June (1998).
33. Sanislo SR, Lowder CY, Zegarra H, Dailey JP, Gutman FA,
and Kaiser PK. Corticosteroid therapy for optic nerve neovascularization
secondary to chronic vitritis. Paper presented at Cleveland
Clinic Foundation Eye Institute Annual Resident's Research
Day, Cleveland, OH, June (1998).
34. Lowder CY, Sanislo SR, Meisler DM, Kozmorsky GS, Rice
TW, Meziane MA, and Kaiser PK. Chest computerized tomography
in the work-up of uveitis. Paper presented at Cleveland Clinic
Foundation Eye Institute Annual Resident's Research Day, Cleveland,
OH, June (1998).
35. Kaiser PK, Clark WL, Belfort A, Miller D, Meisler DM,
Flynn HW. Treatment strategies and visual acuity outcomes
in chronic postoperative Propionibacterium acnes endophthalmitis.
Paper presented at Cleveland Clinic Foundation Eye Institute
Annual Resident's Research Day, Cleveland, OH, June (1998).
36. Kaiser PK and Lewis HL. Angled, illuminated, diamond
knife for the treatment of diabetic fibrovascular proliferation.
Paper presented at 12th Annual Nantucket Retina Symposium,
Nantucket, MA, July (1998).
37. Lowder CY, Sanislo SR, Meisler DM, Kozmorsky GS, Rice
TW, Meziane MA, and Kaiser PK. Chest computerized tomography
in the work-up of uveitis. Paper presented at Cleveland Clinic
Foundation Annual Research Day, Cleveland, OH, October (1998).
38. Kaiser PK, Lowder CY, Sanislo SR, Meisler DM, Kozmorsky
GS, Rice TW, and Meziane MA. Chest computerized tomography
in the work up of chronic, bilateral uveitis. Poster presented
at the American Academy of Ophthalmology Annual Meeting, New
Orleans, LA November (1998).
39. Clark WL, Kaiser PK, Belfort A, Miller D, Meisler DM,
Flynn HW. Treatment strategies and visual acuity outcomes
in chronic postoperative Propionibacterium acnes endophthalmitis.
Poster presented at the American Academy of Ophthalmology
Annual Meeting, New Orleans, LA November (1998).
40. Kaiser PK, Kamei M, Lewis H, Zhou T, Schwendeman SP.
A biodegradable, implantable, multi-drug polymer for the treatment
of proliferative vitreoretinopathy. Paper presented at the
Rod and Cone Club, Vail, CO (1999).
41. Gindzin Y, Riemann CR, Kaiser PK, Trupiano J, Ratcliff
NB. Frayed collagen fibrils are present in the sclera of a
patient with idiopathic uveal effusion syndrome. Investigative
Ophthalmology & Visual Science 40(Suppl):5019 (1999).
42. Kaiser PK, Kamei M, Lewis H. An experimental porcine
model for proliferative vitreoretinopathy. Investigative Ophthalmology
& Visual Science 40(Suppl):5024 (1999).
43. Lewis H, Kamei M, Kaiser PK, Zhou T, Schwendeman SP.
A continuously released, multi-drug, biodegradable polymer
implant for preventing proliferative vitreoretinopathy. Investigative
Ophthalmology & Visual Science 40(Suppl):5129 (1999).
44. Riemann CR, Kaiser PK, Sears JE, Lewis H. Optical coherence
tomography evaluation of diabetic macular edema due to posterior
hyaloidal traction. Investigative Ophthalmology & Visual
Science 40(Suppl):680 (1999).
45. Kaiser PK, Riemann CR, Sears JE, Lewis H. Optical coherence
tomography evaluation of diabetic macular edema due to posterior
hyaloidal traction. Paper presented at Cleveland Clinic Foundation
Eye Institute Annual Resident's Research Day, Cleveland, OH,
June (1999).
46. Lewis H, Kamei M, Kaiser PK, Zhou T, Schwendeman SP.
A continuously released, multi-drug, biodegradable polymer
implant for preventing proliferative vitreoretinopathy. Paper
presented at Cleveland Clinic Foundation Eye Institute Annual
Resident's Research Day, Cleveland, OH, June (1999).
47. Kaiser PK, Kamei M, Lewis H, Zhou T, Schwendeman SP.
A continuously released, multi-drug, biodegradable polymer
implant for preventing proliferative vitreoretinopathy. Paper
presented at 13th Annual Nantucket Retina Symposium, Nantucket,
MA, July (1999).
48. Lowder CY, Sanislo SR, Meisler DM, Kozmorsky GS, Rice
TW, Meziane MA, and Kaiser PK. Chest computerized tomography
in the work-up of uveitis. Paper presented at the Ophthalmology
and Visual Sciences in the 21st Century, Cleveland, OH, September
(1999).
49. Kaiser PK, Riemann CR, Sears JE, Lewis H. Optical coherence
tomography evaluation of diabetic macular edema due to posterior
hyaloidal traction. Poster presented at the Ophthalmology
and Visual Sciences in the 21st Century, Cleveland, OH, September
(1999).
50. Kaiser PK. New developments in the surgical treatment
of diabetic retinopathy. Paper presented at the Ophthalmology
and Visual Sciences in the 21st Century, Cleveland, OH, September
(1999).
51. Sanislo SR, Lowder CY, Zegarra H, Dailey JP, Gutman FA,
and Kaiser PK. Corticosteroid therapy for optic nerve neovascularization
secondary to chronic vitritis. Poster presented at the Ophthalmology
and Visual Sciences in the 21st Century, Cleveland, OH, September
(1999).
52. Clark WL, Kaiser PK, Belfort A, Miller D, Meisler DM,
Flynn HW. Treatment strategies and visual acuity outcomes
in chronic postoperative Propionibacterium acnes endophthalmitis.
Poster presented at the Ophthalmology and Visual Sciences
in the 21st Century, Cleveland, OH, September (1999).
53. Kamei M, Kaiser PK, Zhou T, Schwendeman SP, and Lewis
H. A continuously-released, bio-erodable, polymer implant
for preventing proliferative vitreoretinopathy. Poster presented
at the Ophthalmology and Visual Sciences in the 21st Century,
Cleveland, OH, September (1999).
54. Lewis H, Kamei M, Kaiser PK, Zhou T, and Schwendeman
SP. A continuously-released, multidrug, biodegradable, polymer
implant for preventing proliferative vitreoretinopathy. Paper
presented at 2nd Vitreoretinal Symposium, Marburg, Germany,
October (1999).
55. Kaiser PK. Vitreoretinal Update - Experimental treatments
for diabetic retinopathy. Paper presented at the Joint American
Academy of Ophthalmology and Pan-American Association of Ophthalmology
Symposia, Orlando, FL, October (1999).
56. Kaiser PK, Riemann CR, Sears JE, Lewis H. Optical coherence
tomography (OCT) evaluation of diabetic macular edema due
to posterior hyaloidal traction. Poster presented at the American
Academy of Ophthalmology Annual Meeting, Orlando, FL, October
(1999).
57. Riemann CR, Kaiser PK, Trupiano J, Ratcliff NB. Frayed
collagen fibrils are present in the sclera of a patient with
idiopathic uveal effusion syndrome. Poster presented at the
American Academy of Ophthalmology Annual Meeting, Orlando,
FL, October (1999).
58. Estafanous MFG, Kaiser PK, and Bowen A. Posterior sub-tenon's
kenalog injections in diabetic macular edema. Investigative
Ophthalmology & Visual Science 41(Suppl):589 (2000).
59. Clark WL, Kaiser PK, Flynn HW, Belfort A, and Miller
D. Intravitreal dexamethasone in the treatment of acute-onset
postoperative endophthalmitis. Investigative Ophthalmology
& Visual Science 41(Suppl):1864 (2000).
60. Gindzen Y and Kaiser PK. Acute postoperative endophthalmitis
treated with and without intravitreal dexamethasone. Investigative
Ophthalmology & Visual Science 41(Suppl):1865 (2000).
61. Dandy RM and Kaiser PK. The use of long-acting gas tamponade
in complicated diabetic vitrectomies. Investigative Ophthalmology
& Visual Science 41(Suppl):3495 (2000).
62. Roth DB, Dandy RM, Lowder CL, Kaiser PK, and Sears JE.
Acute retina necrosis: clinical features and long-term follow-up.
Investigative Ophthalmology & Visual Science 41(Suppl):4134
(2000).
63. Dandy RM and Kaiser PK. The use of long-acting gas tamponade
in complicated diabetic vitrectomies. Paper presented at the
American Academy of Ophthalmology Annual Meeting, Dallas,
TX, October (2000).
64. Estafanous MFG, Kaiser PK, and Bowen A. Posterior sub-tenon's
kenalog injections in diabetic macular edema. Poster presented
at the American Academy of Ophthalmology Annual Meeting, Dallas,
TX, October (2000).
65. Riemann CR, Kaiser PK, Trupiano J, Ratcliff NB. Frayed
collagen fibrils are present in the sclera of a patient with
idiopathic uveal effusion syndrome. Poster presented at the
American Academy of Ophthalmology Annual Meeting, Dallas,
TX, October (2000).
66. Lewis H, Kaiser PK, Sears JE, Optical coherence tomography
(OCT) evaluation of diabetic macular edema due to posterior
hyaloidal traction. Retina Society, Coral Gables, FL, December
(2000).
67. Kaiser PK, Filsecker LH, and Smith SD. Therapy of subfoveal
choroidal neovascularization in age-related macular degeneration
with verteporfin: Early angiographic and anatomic findings.
Paper presented at the Cleveland Ophthalmology Society March
2001.
68. Estafanous MFG, Lowder CY, Kaiser PK. Optical Coherence
Tomography evaluation of macular edema in patients with uveitis.
Poster presented at the Options, Controversies, and New Developments
In Vitreoretinal Diseases and Surgery course. Cleveland, OH,
April 2001.
69. Estafanous MFG, Kaiser PK, and Bowen A. Posterior sub-tenon's
kenalog injections in diabetic macular edema. Poster presented
at the Options, Controversies, and New Developments In Vitreoretinal
Diseases and Surgery course. Cleveland, OH, April 2001.
70. Gindzin Y, Clark WL, Miller D, Belfort A, Flynn H, Kaiser
PK. Acute post operative endophthalmitis following cataract
extraction or secondary lens implantation treated with intravitreal
dexamethasone. Poster presented at the Options, Controversies,
and New Developments In Vitreoretinal Diseases and Surgery
course. Cleveland, OH, April 2001.
71. Filsecker LH, Kaiser PK, Smith SD. Photodynamic therapy
of subfoveal choroidal neovascularization with verteporfin:
Early angiographic and anatomical findings. Investigative
Ophthalmology & Visual Science 42(Suppl):1640 (2001).
72. Estafanous MFG, Lowder CY, Kaiser PK. Optical Coherence
Tomography evaluation of macular edema in patients with uveitis.
Investigative Ophthalmology & Visual Science 42(Suppl):2510
(2001).
73. Lam LA, Sears JE, Kaiser PK, Lewis H. Pediatric macular
holes: etiologies, functional and anatomic outcomes after
vitreoretinal surgery. Investigative Ophthalmology & Visual
Science 42(Suppl):3709 (2001).
74. Gindzin Y, Clark WL, Miller D, Belfort A, Flynn H, Kaiser
PK. Acute post operative endophthalmitis following cataract
extraction or secondary lens implantation treated with intravitreal
dexamethasone. Investigative Ophthalmology & Visual Science
42(Suppl):1342 (2001).
75. Estafanous MFG, Lowder CY, Kaiser PK. Optical Coherence
Tomography in the evaluation of macular edema in patients
with uveitis. Poster presented at Cole Eye Institute Annual
Residents and Alumni Meeting, Cleveland, OH, June (2001).
76. Dandy RM, Lowder CL, Kaiser PK. Acute retina necrosis:
clinical features and long-term follow-up. Poster presented
at Cole Eye Institute Annual Residents and Alumni Meeting,
Cleveland, OH, June (2001).
77. Dandy RM and Kaiser PK. The use of long-acting gas tamponade
in complicated diabetic vitrectomies. Poster presented at
Cole Eye Institute Annual Residents and Alumni Meeting, Cleveland,
OH, June (2001).
78. Estafanous MFG, Kaiser PK, and Bowen A. Posterior sub-tenon's
kenalog injections in diabetic macular edema. Poster presented
at Cole Eye Institute Annual Residents and Alumni Meeting,
Cleveland, OH, June (2001).
79. Gindzen Y and Kaiser PK. Acute postoperative Aspergillus
endophthalmitis. Poster presented at Cole Eye Institute Annual
Residents and Alumni Meeting, Cleveland, OH, June (2001).
80. Moshfeghi DM, Kaiser PK, Sears JE, Johnson M, Sternberg
P, Ratliffe N, Lewis H, Blumenkranz M, Grossniklaus H. Histopathologic
findings of choroidal neovascular membranes treated with Visudyne
photodynamic therapy. Paper presented at Cole Eye Institute
Annual Residents and Alumni Meeting, Cleveland, OH, June (2001).
81. Gindzen Y, Clark WL, Flynn H, Kaiser PK. Acute postoperative
endophthalmitis treated with dexamethasone: The combined experience
of the Cole Eye Institute and Bascom Palmer Eye Institute.
Paper presented at Cole Eye Institute Annual Residents and
Alumni Meeting, Cleveland, OH, June (2001).
82. Kaiser PK, Filsecker LH, Smith SD. Therapy of subfoveal
choroidal neovascularization in age-related macular degeneration
with verteporfin: Early angiographic and anatomic findings.
Paper presented at Cole Eye Institute Annual Residents and
Alumni Meeting, Cleveland, OH, June (2001).
83. Kaiser PK. Vitreoretinal surgery in uveitis. Paper presented
at XXIII Pan-American Congress, Beunos Aires, Argentina, July
2001.
84. Kaiser PK. Steroid Implants. Paper presented at XXIII
Pan-American Congress, Beunos Aires, Argentina, July 2001.
85. Kaiser PK, Filsecker LH, Smith SD. Early angiographic
and anatomic findings after ocular photodynamic therapy of
subfoveal choroidal neovascularization in age-related macular
degeneration. Paper presented at XXIII Pan-American Congress,
Beunos Aires, Argentina, July 2001.
86. Kaiser PK, Binder M, Chua J, Moshfieghi D, and Isada
C. Risk factors and characteristics of endogenous endophthalmitis:
An 18 year review. Poster presented at the American Academy
of Ophthalmology Annual Meeting, New Orleans, LA November
(2001).
87. Lam L, Sears J, Kaiser PK, and Lewis H. Pediatric macular
holes: Etiologies and the role of vitrectomy. Poster presented
at the American Academy of Ophthalmology Annual Meeting, New
Orleans, LA November (2001).
Textbooks
1. Friedman NJ, Pineda R, and Kaiser PK. Massachusetts Eye
and Ear Infirmary Illustrated Manual of Ophthalmology. Philadelphia:
W.B. Saunders Company. (1998)
The 1999 Philadelphia Book Show - First Place, Medical Book
Division
2nd Edition in preparation
Book Chapters
Kaiser PK and Gragoudas ES. The subretinal fibrosis and uveitis
syndrome. In: Jakobiec FA, Adamis AP, and Pineda RP eds. International
Ophthalmology Clinics: Noninfectious Inflammatory Disorders
of the Eye and Adnexa. Boston: Little, Brown and Company.
36(1):145-152.
Kaiser PK and Gragoudas ES. Bone marrow transplant retinopathy.
In: Guyer DR, Yannuzzi LA, Chang S, Shields JA, and Green
WR eds. Retina, Vitreous, Macula. Philadelphia: W.B. Saunders
Company. Vol 1(III):488-497.
Kaiser PK and Gragoudas ES. Radiation retinopathy. In: Guyer
DR, Yannuzzi LA, Chang S, Shields JA, and Green WR eds. Retina,
Vitreous, Macula. Philadelphia: W.B. Saunders Company. Vol
1(III):477-487.
Deignan EM, Dubin DB, Kaiser PK, and Kupper TS. Skin and
mucous membrane disorders of the periorbital region. In: Albert
D & Jakobiec FA eds. Principles and Practice of Ophthalmology
2nd edition: W.B. Saunders Company. Vol 5(XVII):4700-4730.
Kaiser PK and Lewis HL. Pars plana vitrectomy for diabetic
macular edema associated with posterior hyaloidal traction.
In: Peyman, GA, Meffert SA, Conway MD, Chou F eds. Vitreoretinal
Surgical Techniques. London, UK: Martin Duntz. Vol 1(V):267-272.
[Back]
|
